News Archive

Dozens of UAlbany Researchers Among World’s Top 2% of Scientists
The annual Stanford University report, published through Elsevier, creates a public database of top-cited researchers.

Professor Thomas Begley Awarded Williams-Raycheff Endowed Professorship
UAlbany Distinguished Professor and Associate Director of the RNA Institute Thomas Begley has been honored with Williams-Raycheff Endowed Professorship, recognizing his pioneering work on RNA biology, big data analysis and his leadership in training the next generation of RNA researchers.

Gov. Hochul Announces $50M Life Sciences Expansion for RNA Institute research
The Life Sciences Research Building, which is home to cutting-edge labs where researchers from the RNA Institute blend bench science with AI to help accelerate the development of RNA-based treatments for deadly diseases, will expand by 20,000 s.f.

UAlbany Spinoff Secures New Funding in Bid to Transform Biotechnology
UAlbany’s Professor Scott Tenenbaum, CEO of UAlbany spinoff company sxRNA Technologies, Inc., brought in over $625,000 in new awards to the company in 2025. With the help of this new funding, the company is positioned to advance their technology for applications in medical research, pharmaceutical production and the development of new precision therapeutics.

In Fall Address, President Rodríguez Praises Successes During Difficult Times for Higher Ed
The president noted high points, including alum Omar Yaghi being awarded a Nobel Prize in chemistry, and the University being recertified for the Seal of Excelencia as well as earning an eighth consecutive Higher Education Excellence and Distinction award.

Solving Biotech Pain Points with RNA Switches: Q&A with Doctoral Student Tia Swenty
Doctoral student Tia Swenty shares insights on her path to nanobiotechnology, the problems she is working to solve, and how thoughtful market research can inform the pursuit of science for real-world impact.

UAlbany, VCU to share $6.5M to Launch Muscular Dystrophy Research Center
With this award — one of just six in the nation — UAlbany and VCU will receive $6.5 million over five years to establish the center under the leadership of UAlbany’s Keith Hynes Endowed Professor in STEM Andy Berglund, director of UAlbany’s RNA Institute, and Dr. Nicholas Johnson, director of VCU’s Center for Inherited Muscle Research.

UAlbany Chemists Design Candidate Drug Against Diabetes
Researchers from UAlbany and NYU Grossman School of Medicine have found a way to block a key cellular pathway known to drive chronic inflammation and impaired wound healing in people with diabetes. The breakthrough could offer a new therapeutic option for stopping the harmful effects of both type 1 and type 2 diabetes at the source.